| 1 | | $860B | $904.87 | -2.02% | |
| 2 | | $400B | $166.17 | -0.49% | |
| 3 | | $341B | $192.91 | -1.44% | |
| 4 | | $301B | $118.67 | +0.6% | |
| 5 | | $200B | $114.88 | -2.34% | |
| 6 | | $179B | $332.93 | -0.69% | |
| 7 | | $171B | $481.99 | -1.91% | |
| 8 | | $169B | $29.75 | -1.06% | |
| 9 | | $138B | $361.19 | -2.9% | |
| 10 | Regeneron Pharmaceuticals | $126B | $1,139.06 | -1.22% | |
| 11 | | $122B | $474.16 | -3.12% | |
| 12 | | $122B | $82.58 | -1.11% | |
| 13 | | $113B | $88.13 | -2.2% | |
| 14 | | $105B | $83.90 | +0.89% | |
| 15 | | $103B | $400.05 | -0.84% | |
| 16 | | $101B | $49.74 | -0.51% | |
| 17 | | $89.1B | $196.57 | +1.19% | |
| 18 | | $73.3B | $133.35 | -0.94% | |
| 19 | | $67B | $231.75 | -0.98% | |
| 20 | | $66.4B | $511.72 | -1.56% | |
| 21 | | $44.8B | $228.47 | -5.29% | |
| 22 | | $42.1B | $511.33 | -0.01% | |
| 23 | | $40.7B | $67.53 | -2.64% | |
| 24 | | $40.4B | $88.53 | +2.18% | |
| 25 | | $35.1B | $273.18 | +1.04% | |
